ASCL1 and glioma: In summary, this proof-of-concept study indicated that the single transcription factor ASCL1 was sufficient to high-efficiently reprogram human glioma cells into non-proliferating neurons and restricted tumor growth, suggestive of a promising potential for brain tumor treatment.